ABSTRACT
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.
Subject(s)
Graves Disease , Graves Ophthalmopathy , Antithyroid Agents/therapeutic use , Female , Graves Disease/drug therapy , Graves Disease/therapy , Graves Ophthalmopathy/diagnosis , Graves Ophthalmopathy/epidemiology , Graves Ophthalmopathy/etiology , Humans , Iodine Radioisotopes/therapeutic use , Pregnancy , ThyroidectomyABSTRACT
Silent sinus syndrome (SSS) is a rare disorder involving bony remodeling of the maxillary sinuses, including collapse of the orbital floor. It is typically unilateral and seen in the setting of chronic maxillary sinusitis. Patients present with enophthalmos and hypoglobus occasionally accompanied by diplopia. The condition is generally diagnosed with CT imaging and treated surgically. While SSS is most often reported as very slowly progressive, we report a patient with evidence of significant remodeling of the maxillary sinus over a period of 5.5 months.
